Mechanisms of Resistance of Malaria Parasites to Antifolates
Top Cited Papers
- 24 February 2005
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 57 (1), 117-145
- https://doi.org/10.1124/pr.57.1.4
Abstract
Antifolate antimalarial drugs interfere with folate metabolism, a pathway essential to malaria parasite survival. This class of drugs includes effective causal prophylactic and therapeutic agents, some of which act synergistically when used in combination. Unfortunately, the antifolates have proven susceptible to resistance in the malaria parasite. Resistance is caused by point mutations in dihydrofolate reductase and dihydropteroate synthase, the two key enzymes in the folate biosynthetic pathway that are targeted by the antifolates. Resistance to these drugs arises relatively rapidly in response to drug pressure and is now common worldwide. Nevertheless, antifolate drugs remain first-line agents in several sub-Saharan African countries where chloroquine resistance is widespread, at least partially because they remain the only affordable, effective alternative. New antifolate combinations that are more effective against resistant parasites are being developed and in one case, recently introduced into use. Combining these antifolates with drugs that act on different targets in the parasite should greatly enhance their effectiveness as well as deter the development of resistance. Molecular epidemiological techniques for monitoring parasite drug resistance may contribute to development of strategies for prolonging the useful therapeutic life of this important class of drugs.Keywords
This publication has 101 references indexed in Scilit:
- Drug development for neglected diseases: a deficient market and a public-health policy failureThe Lancet, 2002
- Crystal structure of Mycobacterium tuberculosis 6-hydroxymethyl-7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action 1 1Edited by I. WilsonJournal of Molecular Biology, 2000
- Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugsJournal of Molecular Biology, 2000
- More on ‘The Efficacy of Antifolate Antimalarial Combinations in Africa'Parasitology Today, 1999
- Models to predict the intensity of Plasmodium falciparum transmission: applications to the burden of disease in KenyaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Resistance to chloroquine of Plasmodium falciparum from BurmaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1972
- SULPHORMETHOXINE IN CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN THAILANDThe Lancet, 1967
- ST. GEORGE'S HOSPITALThe Lancet, 1824